1
项与 Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University) 相关的临床试验A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, Pharmacodynamics and Immunogenicity of Universal CNK-UT Cells in Patients With Advanced Solid Tumors.
This is a single arm, open-label, multi-center, phase I study to evaluate the safety, tolerability, preliminary efficacy, pharmacodynamics and immunogenicity of universal chimeric natural killer receptor modified T-cells (CNK-UT) targeting NKG2D-Ligands and NCR2-Ligands with or without lymphodepletion in advanced solid tumors.
100 项与 Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University) 相关的临床结果
100 项与 Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University) 相关的转化医学
100 项与 Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University) 相关的专利(医药)
100 项与 Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University) 相关的药物交易